Emily M Le

Array ( [id] => 5624881 [patent_doc_number] => 20060263386 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-23 [patent_title] => 'Vaccines' [patent_app_type] => utility [patent_app_number] => 10/550754 [patent_app_country] => US [patent_app_date] => 2004-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 10262 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20060263386.pdf [firstpage_image] =>[orig_patent_app_number] => 10550754 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4999364 [patent_doc_number] => 20070041998 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-22 [patent_title] => 'Use of alum and a th1 immune response inducing adjuvant for enhancing immune responses' [patent_app_type] => utility [patent_app_number] => 10/550820 [patent_app_country] => US [patent_app_date] => 2004-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5088 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20070041998.pdf [firstpage_image] =>[orig_patent_app_number] => 10550820 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5699618 [patent_doc_number] => 20060216302 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-28 [patent_title] => 'Immunological markers' [patent_app_type] => utility [patent_app_number] => 10/547046 [patent_app_country] => US [patent_app_date] => 2004-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17119 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20060216302.pdf [firstpage_image] =>[orig_patent_app_number] => 10547046 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7677170 [patent_doc_number] => 20040152656 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-05 [patent_title] => 'Immunomodulatory oligonucleotides' [patent_app_type] => new [patent_app_number] => 10/788191 [patent_app_country] => US [patent_app_date] => 2004-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11312 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20040152656.pdf [firstpage_image] =>[orig_patent_app_number] => 10788191 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7672886 [patent_doc_number] => 20040180893 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-16 [patent_title] => 'Identification of compounds that inhibit replication of human immunodeficiency virus' [patent_app_type] => new [patent_app_number] => 10/783053 [patent_app_country] => US [patent_app_date] => 2004-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 29301 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20040180893.pdf [firstpage_image] =>[orig_patent_app_number] => 10783053 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 483378 [patent_doc_number] => 07220768 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-05-22 [patent_title] => 'Isoxazole-containing thiourea inhibitors useful for treatment of varicella zoster virus' [patent_app_type] => utility [patent_app_number] => 10/772799 [patent_app_country] => US [patent_app_date] => 2004-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5209 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/220/07220768.pdf [firstpage_image] =>[orig_patent_app_number] => 10772799 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7225303 [patent_doc_number] => 20050255097 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-17 [patent_title] => 'Modified venom and venom components as anti-retroviral agents' [patent_app_type] => utility [patent_app_number] => 10/764356 [patent_app_country] => US [patent_app_date] => 2004-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10120 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0255/20050255097.pdf [firstpage_image] =>[orig_patent_app_number] => 10764356 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7163155 [patent_doc_number] => 20050085435 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-21 [patent_title] => 'Novel inhibitors of poxvirus replication' [patent_app_type] => utility [patent_app_number] => 10/750939 [patent_app_country] => US [patent_app_date] => 2004-01-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 8641 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0085/20050085435.pdf [firstpage_image] =>[orig_patent_app_number] => 10750939 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7425706 [patent_doc_number] => 20040161470 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-19 [patent_title] => 'Preparation of polyphosphazene microspheres' [patent_app_type] => new [patent_app_number] => 10/715787 [patent_app_country] => US [patent_app_date] => 2003-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3220 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20040161470.pdf [firstpage_image] =>[orig_patent_app_number] => 10715787 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 63007 [patent_doc_number] => 07758876 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-07-20 [patent_title] => 'Method of preventing infections from bioterrorism agents with immunostimulatory CpG oligonucleotides' [patent_app_type] => utility [patent_app_number] => 10/533634 [patent_app_country] => US [patent_app_date] => 2003-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 19913 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/758/07758876.pdf [firstpage_image] =>[orig_patent_app_number] => 10533634 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7410850 [patent_doc_number] => 20040106539 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-03 [patent_title] => 'Agents for the treatment of viral infections' [patent_app_type] => new [patent_app_number] => 10/398993 [patent_app_country] => US [patent_app_date] => 2003-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 30294 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20040106539.pdf [firstpage_image] =>[orig_patent_app_number] => 10398993 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7333201 [patent_doc_number] => 20040131604 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'Methods for inhibiting viral replication in vivo' [patent_app_type] => new [patent_app_number] => 10/674666 [patent_app_country] => US [patent_app_date] => 2003-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18091 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20040131604.pdf [firstpage_image] =>[orig_patent_app_number] => 10674666 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7475113 [patent_doc_number] => 20040122217 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-24 [patent_title] => 'Lectin compositions and methods for modulating an immune response to an antigen' [patent_app_type] => new [patent_app_number] => 10/666871 [patent_app_country] => US [patent_app_date] => 2003-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 67740 [patent_no_of_claims] => 68 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 147 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20040122217.pdf [firstpage_image] =>[orig_patent_app_number] => 10666871 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7264839 [patent_doc_number] => 20040151728 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-05 [patent_title] => 'Lectin compositions and methods for modulating an immune response to an antigen' [patent_app_type] => new [patent_app_number] => 10/666834 [patent_app_country] => US [patent_app_date] => 2003-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 218036 [patent_no_of_claims] => 77 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0151/20040151728.pdf [firstpage_image] =>[orig_patent_app_number] => 10666834 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7310455 [patent_doc_number] => 20040142889 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-22 [patent_title] => 'Lectin compositions and methods for modulating an immune response to an antigen' [patent_app_type] => new [patent_app_number] => 10/666898 [patent_app_country] => US [patent_app_date] => 2003-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 67756 [patent_no_of_claims] => 69 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 152 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20040142889.pdf [firstpage_image] =>[orig_patent_app_number] => 10666898 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7675325 [patent_doc_number] => 20040126793 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-01 [patent_title] => 'Lectin compositions and methods for modulating an immune response to an antigen' [patent_app_type] => new [patent_app_number] => 10/666885 [patent_app_country] => US [patent_app_date] => 2003-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 201140 [patent_no_of_claims] => 147 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 152 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0126/20040126793.pdf [firstpage_image] =>[orig_patent_app_number] => 10666885 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7149299 [patent_doc_number] => 20040170960 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-02 [patent_title] => 'Lectin compositions and methods for modulating an immune response to an antigen' [patent_app_type] => new [patent_app_number] => 10/667193 [patent_app_country] => US [patent_app_date] => 2003-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 67722 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20040170960.pdf [firstpage_image] =>[orig_patent_app_number] => 10667193 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7461916 [patent_doc_number] => 20040197913 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-07 [patent_title] => 'Methods and means for improving retroviral integration' [patent_app_type] => new [patent_app_number] => 10/658315 [patent_app_country] => US [patent_app_date] => 2003-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 16050 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20040197913.pdf [firstpage_image] =>[orig_patent_app_number] => 10658315 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 892531 [patent_doc_number] => 07345152 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-03-18 [patent_title] => 'Monoclonal antibody specific for an epitope of inactivated feline immunodeficiency-encoded glycoprotein' [patent_app_type] => utility [patent_app_number] => 10/648667 [patent_app_country] => US [patent_app_date] => 2003-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2876 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/345/07345152.pdf [firstpage_image] =>[orig_patent_app_number] => 10648667 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5710027 [patent_doc_number] => 20060051372 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-09 [patent_title] => 'Antigenic compounds' [patent_app_type] => utility [patent_app_number] => 10/524153 [patent_app_country] => US [patent_app_date] => 2003-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7713 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0051/20060051372.pdf [firstpage_image] =>[orig_patent_app_number] => 10524153 [rel_patent_id] =>[rel_patent_doc_number] =>)